5 Questions With Maya Yovcheva, Scientist III at Thermo Fisher Scientific

Published on :

Maya Yovcheva is an R&D scientist with more than ten years of experience in cell biology, protein expression, and product development. She has been a product development scientist at Thermo Fisher Scientific for six years, developing novel tools and platforms for protein expression and viral vector production. Her work has led to the launch of a new platform for baculovirus-based protein expression in insect cells. Maya holds a bachelor’s degree in Molecular Biology and a Master’s degree in Medical Biotechnology.

Deka Biosciences Raises USD 20 Million in Series A Financing

Deka Biosciences Logo
Published on :

Maryland-based biotech company Deka Biosciences (“Deka”) today announced that it has successfully closed a USD 20 Million Series A financing with a syndicate of life science investors led by Leaps by Bayer, the impact investment arm of Bayer AG, and new investor Lumira Ventures. Additional investors include O-Bio (Echo Investment Capital), Viva BioInnovator, and Alexandria Venture Investments.

2021 BioBuzz Awards Finalists

Published on :

We’re excited to announce this year’s finalists for the second annual 2021 BioBuzz Awards. These awards celebrate the people and companies across our regional community and their efforts and accomplishments to impact human health and build a stronger biotech community.

South Duvall and Sagamore Ventures Team Up to Bring High-End Lab Space to Baltimore’s Port Covington

Photo of City Garage in Baltimore
Published on :

Last week South Duvall and Sagamore Ventures announced that they have formed a partnership to bring more than 100,000 square feet of high-end laboratory space to City Garage in Baltimore’s Port Covington over the next ten years. Approximately 75,000 square feet of space is set to be delivered in the next year alone.

With a Chance to Cure HIV, American Gene Technologies Offers Employees a Front Seat to History

Hand holding blood test vial marked as HIV negative
Published on :

There is a growing movement of professionals seeking jobs with a purpose. The mission-driven culture of a company is a powerful attraction for those value-driven prospective applicants. Curing HIV is one of the bolder missions to be found in the I-270 technology corridor. With its bold mission to develop a cure for HIV, American Gene Technologies Business Development head Norman Rogers said that it’s an “attractive position for people who want a front seat to history.”

Single Cell RNA-Seq Training Workshop

Published on :

This in-depth lecture and hands-on laboratory workshop (wet lab & in silica) is ideal for those research and bench scientists who are interested in a comprehensive introduction to single cell [….]

Seeking Top Biotech Talent? Veterans Have Just What You Need

Published on :

Every month, thousands of military veterans around the world begin their transition out of the military with anywhere between 2 and 20 years of experience in some of the most fast-paced, operationally focused, and regulated environments imaginable. These transitioning service-members and their families all bring an army of benefits to bear for innovative organizations willing to give them a chance. 

5 Questions With Sandy Williams, Ph.D., President and Founder of Access Biomedical Solutions

Headshot of Sandy Williams
Published on :

Sandy is the President and Founder of Access Biomedical Solutions, a consultancy launched in 2015 that is focused on empowering biotech and medtech companies grow and accomplish their goals. She achieves this by combining her technical expertise and marketing skills to quickly identify a company’s current trajectory, what success looks like for them, and what their biggest gaps are.

REGENXBIO Closes $370M+ Gene Therapy Eye Care Collaboration Agreement with AbbVie for Wet AMD and Diabetic Retinopathy

Published on :

REGENXBIO Inc. (Nasdaq: RGNX) today announced the closing of its Collaboration and License Agreement with AbbVie to develop and commercialize RGX-314, a potential one-time gene therapy for the treatment of wet age-related macular degeneration (wet AMD), diabetic retinopathy (DR) and other chronic retinal diseases.

Gene Editing with CRISPR Training Workshop

Published on :

This rigorous three day program is ideal for basic research and translational biology scientists who are looking for a balanced theoretical vs. hands-on introduction to CRISPR toolkit. Taught by active [….]